Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-02

Clinical Trial Update: The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation [NA]

View source ↗

Summary

A completed clinical trial evaluating the non-hormonal COX-2 inhibitor Celebrex on ovulation and luteal development; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELEBREX (Celecoxib)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Ovulation, Luteal Development | NA | Status: COMPLETED | Results posted: 2014-07-02